Axsome Therapeutics, Inc. financial data

Symbol
AXSM on Nasdaq
Industry
Pharmaceutical Preparations
Location
One World Trade Center, 22 Nd Floor, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 389 % +28.9%
Quick Ratio 9.75 % +18.5%
Debt-to-equity 166 % -22.9%
Return On Equity -134 % +16.7%
Return On Assets -50.5 % +1.31%
Operating Margin -117 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.5 M shares +9%
Common Stock, Shares, Outstanding 47.5 M shares +8.99%
Entity Public Float 2.8 B USD +133%
Common Stock, Value, Issued 5 K USD +25%
Weighted Average Number of Shares Outstanding, Basic 47.4 M shares +8.89%
Weighted Average Number of Shares Outstanding, Diluted 47.4 M shares +8.89%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 251 M USD -20.7%
Cost of Revenue 5.2 M USD
Research and Development Expense 117 M USD +85.2%
General and Administrative Expense 81.1 M USD +131%
Costs and Expenses 544 M USD +85.9%
Operating Income (Loss) -293 M USD -97.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -298 M USD -90.9%
Income Tax Expense (Benefit) -1.62 M USD -100%
Net Income (Loss) Attributable to Parent -296 M USD -86.7%
Earnings Per Share, Basic -6.45 USD/shares -69.7%
Earnings Per Share, Diluted -6.45 USD/shares -69.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 331 M USD +34.5%
Accounts Receivable, after Allowance for Credit Loss, Current 101 M USD +126%
Inventory, Net 15.6 M USD +96.3%
Assets, Current 460 M USD +51.3%
Property, Plant and Equipment, Net 812 K USD +15.5%
Operating Lease, Right-of-Use Asset 6.41 M USD +5948%
Intangible Assets, Net (Excluding Goodwill) 51.7 M USD -11%
Goodwill 12 M USD +16.8%
Other Assets, Noncurrent 507 K USD +59.9%
Assets 546 M USD +40.2%
Accounts Payable, Current 53.8 M USD +50.4%
Employee-related Liabilities, Current 16.1 M USD +122%
Liabilities, Current 144 M USD +43.1%
Operating Lease, Liability, Noncurrent 7.26 M USD
Liabilities 402 M USD +44.8%
Retained Earnings (Accumulated Deficit) -904 M USD -48.8%
Stockholders' Equity Attributable to Parent 144 M USD +28.8%
Liabilities and Equity 546 M USD +40.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.5 M USD -819%
Net Cash Provided by (Used in) Financing Activities -1.19 M USD -102%
Net Cash Provided by (Used in) Investing Activities -98 K USD -38%
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 47.5 M shares +8.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -54.8 M USD -220%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 331 M USD +34.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.9 M USD +52.5%
Deferred Tax Assets, Valuation Allowance 223 M USD +21.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 225 M USD +22%
Operating Lease, Liability 8.41 M USD +7688%
Depreciation 132 K USD +46.7%
Payments to Acquire Property, Plant, and Equipment 98 K USD +38%
Lessee, Operating Lease, Liability, to be Paid 11.3 M USD +10358%
Operating Lease, Liability, Current 1.15 M USD +968%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.52 M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.93 M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.88 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.52 M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.2 M USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.39 M USD +1.08%
Share-based Payment Arrangement, Expense 7.31 M USD -43.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%